Systemic lupus erythematosus and antiphospholipid syndrome

Fawzi Saoud, Maged Costantine

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory condition that affects virtually every organ system. Management of both SLE and antiphospholipid syndrome (APS) during pregnancy requires vigilance for signs and symptoms of disease exacerbation, aggressive treatment when needed, and careful assessment of fetal well-being. A multidisciplinary approach is essential and should include a maternal-fetal medicine specialist, a rheu matologist, the patient’s obstetrician, and, if renal disease is present, a nephrologist. Women with SLE are at risk for several obstetric complications, sometimes resulting in serious maternal and perinatal morbidity. Breastfeeding is considered safe for women with SLE since hydroxychlo roquine, azathioprine, and prednisone all have very limited transfer into breast milk and may be continued during this critical time. Some APS-related pregnancy complications, particularly fetal loss, are probably related to abnormal placental function due to narrowing and thrombosis in decidual spiral arteries.

Original languageEnglish (US)
Title of host publicationCritical Care Obstetrics
Publisherwiley
Pages873-889
Number of pages17
ISBN (Electronic)9781119129400
ISBN (Print)9781119129370
DOIs
StatePublished - Jan 1 2018

Fingerprint

Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Mothers
Pregnancy Complications
Azathioprine
Human Milk
Prednisone
Breast Feeding
Obstetrics
Signs and Symptoms
Disease Progression
Thrombosis
Arteries
Medicine
Morbidity
Kidney
Pregnancy
Therapeutics

Keywords

  • Antiphospholipid syndrome
  • Breastfeeding
  • Maternal-fetal medicine specialist
  • Obstetric complications
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Saoud, F., & Costantine, M. (2018). Systemic lupus erythematosus and antiphospholipid syndrome. In Critical Care Obstetrics (pp. 873-889). wiley. https://doi.org/10.1002/9781119129400.ch51

Systemic lupus erythematosus and antiphospholipid syndrome. / Saoud, Fawzi; Costantine, Maged.

Critical Care Obstetrics. wiley, 2018. p. 873-889.

Research output: Chapter in Book/Report/Conference proceedingChapter

Saoud, F & Costantine, M 2018, Systemic lupus erythematosus and antiphospholipid syndrome. in Critical Care Obstetrics. wiley, pp. 873-889. https://doi.org/10.1002/9781119129400.ch51
Saoud F, Costantine M. Systemic lupus erythematosus and antiphospholipid syndrome. In Critical Care Obstetrics. wiley. 2018. p. 873-889 https://doi.org/10.1002/9781119129400.ch51
Saoud, Fawzi ; Costantine, Maged. / Systemic lupus erythematosus and antiphospholipid syndrome. Critical Care Obstetrics. wiley, 2018. pp. 873-889
@inbook{3c3bd2c0898646d7a9ed496270fb21d8,
title = "Systemic lupus erythematosus and antiphospholipid syndrome",
abstract = "Systemic lupus erythematosus (SLE) is a chronic inflammatory condition that affects virtually every organ system. Management of both SLE and antiphospholipid syndrome (APS) during pregnancy requires vigilance for signs and symptoms of disease exacerbation, aggressive treatment when needed, and careful assessment of fetal well-being. A multidisciplinary approach is essential and should include a maternal-fetal medicine specialist, a rheu matologist, the patient’s obstetrician, and, if renal disease is present, a nephrologist. Women with SLE are at risk for several obstetric complications, sometimes resulting in serious maternal and perinatal morbidity. Breastfeeding is considered safe for women with SLE since hydroxychlo roquine, azathioprine, and prednisone all have very limited transfer into breast milk and may be continued during this critical time. Some APS-related pregnancy complications, particularly fetal loss, are probably related to abnormal placental function due to narrowing and thrombosis in decidual spiral arteries.",
keywords = "Antiphospholipid syndrome, Breastfeeding, Maternal-fetal medicine specialist, Obstetric complications, Systemic lupus erythematosus",
author = "Fawzi Saoud and Maged Costantine",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/9781119129400.ch51",
language = "English (US)",
isbn = "9781119129370",
pages = "873--889",
booktitle = "Critical Care Obstetrics",
publisher = "wiley",

}

TY - CHAP

T1 - Systemic lupus erythematosus and antiphospholipid syndrome

AU - Saoud, Fawzi

AU - Costantine, Maged

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Systemic lupus erythematosus (SLE) is a chronic inflammatory condition that affects virtually every organ system. Management of both SLE and antiphospholipid syndrome (APS) during pregnancy requires vigilance for signs and symptoms of disease exacerbation, aggressive treatment when needed, and careful assessment of fetal well-being. A multidisciplinary approach is essential and should include a maternal-fetal medicine specialist, a rheu matologist, the patient’s obstetrician, and, if renal disease is present, a nephrologist. Women with SLE are at risk for several obstetric complications, sometimes resulting in serious maternal and perinatal morbidity. Breastfeeding is considered safe for women with SLE since hydroxychlo roquine, azathioprine, and prednisone all have very limited transfer into breast milk and may be continued during this critical time. Some APS-related pregnancy complications, particularly fetal loss, are probably related to abnormal placental function due to narrowing and thrombosis in decidual spiral arteries.

AB - Systemic lupus erythematosus (SLE) is a chronic inflammatory condition that affects virtually every organ system. Management of both SLE and antiphospholipid syndrome (APS) during pregnancy requires vigilance for signs and symptoms of disease exacerbation, aggressive treatment when needed, and careful assessment of fetal well-being. A multidisciplinary approach is essential and should include a maternal-fetal medicine specialist, a rheu matologist, the patient’s obstetrician, and, if renal disease is present, a nephrologist. Women with SLE are at risk for several obstetric complications, sometimes resulting in serious maternal and perinatal morbidity. Breastfeeding is considered safe for women with SLE since hydroxychlo roquine, azathioprine, and prednisone all have very limited transfer into breast milk and may be continued during this critical time. Some APS-related pregnancy complications, particularly fetal loss, are probably related to abnormal placental function due to narrowing and thrombosis in decidual spiral arteries.

KW - Antiphospholipid syndrome

KW - Breastfeeding

KW - Maternal-fetal medicine specialist

KW - Obstetric complications

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=85060655318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060655318&partnerID=8YFLogxK

U2 - 10.1002/9781119129400.ch51

DO - 10.1002/9781119129400.ch51

M3 - Chapter

SN - 9781119129370

SP - 873

EP - 889

BT - Critical Care Obstetrics

PB - wiley

ER -